Cytogenetic patterns in ETV6/RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia: A Nordic series of 245 cases and review of the literature

Genes Chromosomes and Cancer

Volumn 46, Issue 5, 2007, Pages 440-450

  Forestier, Erik ^a   Andersen, Mette K ^b   Autio, Kirsi ^c   Blennow, Elisabeth ^d   Borgström, Georg ^c   Golovleva, Irina ^a   Heim, Sverre ^e,f   Heinonen, Kristina ^g   Hovland, Randi ^h   Johannsson, Johann H ⁱ   Kerndrup, Gitte ^j   Nordgren, Ann ^d   Rosenquist, Richard ^k   Swolin, Birgitta ^l   Johansson, Bertil ^m  

^a UMEÅ UNIVERSITY   (Sweden)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

ⁱ LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^j ODENSE UNIVERSITY HOSPITAL   (Denmark)

^k UPPSALA UNIVERSITY   (Sweden)

^l SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^m LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CHILD; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 21Q; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME NUMBER; CHROMOSOME TRANSLOCATION 12; ETV6 GENE; FEMALE; GENE; GENE FUNCTION; HUMAN; KARYOTYPE; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; REVIEW; RUNX1 GENE; TETRAPLOIDY; TRIPLOIDY; X CHROMOSOME;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; HUMANS; ICELAND; LEUKEMIA, T-CELL, ACUTE; SCANDINAVIA; TRANSCRIPTION FACTORS;

EID: 33947430093     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20423     Document Type: Review

References (103)

1. Alessandri AJ, Reid GSD, Bader SA, Massing BG, Sorensen PHB, Schultz KR. 2002. ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype. Br J Haematol 116:266-272.
2. Alvarez Y, Coll MD, Ortega JJ, Bastida P, Dastugue N, Robert A, Cervera J, Verdeguer A, Tasso M, Aventín A, Guitart M, Caballín MR. 2005. Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia. Cancer Genet Cytogenet 162:21-29.
3. Ameye G, Jacquy C, Zenebergh A, Stul M, Vaerman JL, Bilhou-Nabera C, Libouton JM, Deneys V, Martiat P, Hagemeijer A, Cornu G, Verellen-Dumoulin C, Michaux L. 2000. The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia. Ann Hematol 79:259-268.
4. Amor DJ, Algar EM, Slater HR, Smith PJ. 1998. High frequency of t(12:21) in childhood acute lymphoblastic leukemia detected by RT-PCR. Pathology 30:381-385.
5. Andersson A, Edén P, Lindgren D, Nilsson J, Lassen C, Heldrup J, Fontes M, Borg Å, Mitelman F, Johansson B, Höglund M, Fioretos T. 2005a. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 19:1042-1050.
6. Andersson A, Olofsson T, Lindgren D, Nilsson B, Ritz C, Edén P, Lassen C, RÅde J, Fontes M, Mörse H, Heldrup J, Behrendtz M, Mitelman F, Höglund M, Johansson B, Fioretos T. 2005b. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc Natl Acad Sci USA 102:19069-19074.
7. Andreasson P, Höglund M, Békássy AN, Garwicz S, Heldrup J, Mitelman F, Johansson B. 2000. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias. Eur J Haematol 65:40-51.
8. Andreasson P, Johansson B, Strömbeck B, Donnér M, Mitelman F, Höglund M. 1997. Childhood acute lymphoblastic leukaemia with ider(21)(q10)t(12;21)(p12;q22): A new recurrent abnormality showing ETV6/CBFA2 fusion. Br J Haematol 98:216-218.
9. Andreasson P, Schwaller J, Anastasiadou E, Aster J, Gilliland DG. 2001. The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet 130:93-104.
10. Attarbaschi A, Mann G, König M, Dworzak MN, Trebo MM, Mühlegger N, Gadner H, Haas OA. 2004. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/ AML1+ acute lymphoblastic leukemia: An interphase FISH analysis. Leukemia 18:1611-1616.
11. Attarbaschi A, Mann G, König M, Steiner M, Dworzak MN, Gadner H, Haas OA. 2006. Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/ RUNX1-positive leukemic cases. Genes Chromosomes Cancer 45:608-611.
12. Avigad S, Kuperstein G, Zilberstein J, Liberzon E, Stark B, Gelernter I, Kodman Y, Luria D, Ash S, Stein J, Goshen Y, Yaniv I, Cohen IJ, Zaizov R. 1999. TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia. Leukemia 13:481-483.
13. Baruchel A, Cayuela JM, Ballerini P, Landman-Parker J, Cezard V, Firat H, Haddad E, Auclerc MF, Valensi F, Cayre YE, Macintyre EA, Sigaux F. 1997. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. Br J Haematol 99:101-106.
14. Bernardin F, Yang Y, Cleaves R, Zahurak M, Cheng L, Civin CI, Friedman AD. 2002. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 62:3904-3908.
15. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A. 1997. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 90:571-577.
16. Borowitz MJ, Rubnitz J, Nash M, Pullen DJ, Camitta B. 1998. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: A Pediatric Oncology Group Study. Leukemia 12:1764-1770.
17. Broadfield ZJ, Hain RDW, Harrison CJ, Jalali GR, McKinley M, Michalová K, Robinson HM, Zemanová Z, Martineau M. 2004. Complex chromosomal abnormalities in utero, 5 years before leukaemia. Br J Haematol 126:307-312.
18. Castor A, Nilsson L, Åstrand-Grundström I, Buitenhuis M, Ramirez C, Anderson K, Strömbeck B, Garwicz S, Békássy AN, Schmiegelow K, Lausen B, Hokland P, Lehmann S, Juliusson G, Johansson B, Jacobsen SEW. 2005. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 11:630-637.
19. Cavé H, Cacheux V, Raynaud S, Brunie G, Bakkus M, Cochaux P, Preudhomme C, Laÿ JL, Vilmer E, Grandchamp B. 1997. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia. Leukemia 11:1459-1464.
20. Cayuela JM, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel MT, Schaison G, Sigaux F. 1996. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 88:302-308.
21. Codrington R, O'Connor HE, Jalali GR, Carrara P, Papaioannou M, Hart SM, Hoffbrand AV, Potter M, Prentice HG, Harrison CJ, Foroni L. 2000. Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: Incidence, alternative spliced forms and minimal residual disease value. Br J Haematol 111:1071-1079.
22. De Zen L, Orfao A, Cazzaniga G, Masiero L, Cocito MG, Spinelli M, Rivolta A, Biondi A, Zanesco L, Basso G. 2000. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: Correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia 14:1225-1231.
23. Douet-Guilbert N, Morel F, Le Bris MJ, Herry A, Le Calvez G, Marion V, Abgrall JF, Berthou C, De Braekeleer M. 2003. A fluorescence in situ hybridization study of TEL-AML1 fusion gene in B-cell acute lymphoblastic leukemia (1984-2001). Cancer Genet Cytogenet 144:143-147.
24. Eguchi-Ishimae M, Eguchi M, Ishii E, Miyazaki S, Ueda K, Kamada N, Mizutani S. 2001. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptotic signals. Blood 97:737-743.
25. Eguchi-Ishimae M, Eguchi M, Tanaka K, Hamamoto K, Ohki M, Ueda K, Kamada N. 1998. Fluorescence in situ hybridization analysis of 12;21 translocation in Japanese childhood acute lymphoblastic leukemia. Jpn J Cancer Res 89:783-788.
26. Fears S, Vignon C, Bohlander SK, Smith S, Rowley JD, Nucifora G. 1996. Correlation between the ETV6/CBFA2 (TEL/AMLI) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 17:127-135.
27. Fischer M, Schwieger S, Horn S, Niebuhr B, Ford A, Roscher S, Bergholz U, Greaves M, Löhler J, Stocking C. 2005. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Oncogene 24:7579-7591.
28. Ford AM, Bennett CA, Price CM, Bruin MCA, Van Wering ER, Greaves M. 1998. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 95:4584-4588.
29. Ford AM, Fasching K, Panzer-Grümayer ER, Koenig M, Haas OA, Greaves M. 2001. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood 98:558-564.
30. Forestier E, Schmiegelow K. 2006. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol 28:486-495.
31. García-Sanz R, Alaejos I, Orfão A, Rasillo A, Chillón MC, Tabernero MD, Mateos MV, López-Pérez R, González D, Balanzategui A, Gonzalez M, San Miguel JF. 1999. Low frequency of the TEL/ AML1 fusion gene in acute lymphoblastic leukaemia in Spain. Br J Haematol 107:667-669.
32. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917-4921.
33. Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, Gibson B, Richards S. 2001. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 113:103-114.
34. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. 1997. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 90:4933-4937.
35. Hjalgrim LL, Madsen HO, Melbye M, Jørgensen P, Christiansen M, Andersen MT, Pallisgaard N, Hokland P, Clausen N, Ryder LP, Schmiegelow K, Hjalgrim H. 2002. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 87:994-999.
36. Höglund M, Gisselsson D, Mandahl N, Johansson B, Mertens F, Mitelman F, Säll T. 2001. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 31:156-171.
37. - progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. Blood 100:640-646.
38. Hubeek I, Ramakers-van Woerden NL, Pieters R, Slater R, Beverloo HB, van Wering ER, Kamps W, Hählen K, Veerman AJP. 2001. TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia. Br J Haematol 113:254-255.
39. Inamdar N, Kumar SA, Banavali SD, Advani S, Magrath I, Bhatia K. 1998. Comparative incidence of the rearrangements of TEL/ AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India. Int J Cancer 13:1319-1322.
40. Jabber Al-Obaidi MS, Martineau M, Bennett CF, Franklin IM, Goldstone AH, Harewood L, Jalali GR, Prentice HG, Richards SM, Roberts K, Harrison CJ. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 16:669-674. 2002.
41. Jamil A, Theil KS, Kahwash S, Ruymann FB, Klopfenstein KJ. 2000. TEL/AML-1 fusion gene: Its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 122:73-78.
42. Jaroŝová M, Holzerová M, Jedliĉková K, Mihál V, Zuna J, Starý J, Pospiŝilová D, Zemanová Z, Trka J, Blažek J, Pikalová Z, Indrák K. 2000. Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet 123:114-122.
43. Johansson B, Mertens F, Mitelman F. 1996. Primary vs. secondary neoplasia-associated chromosomal abnormalities-Balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16:155-163.
44. Johansson B, Mertens F, Mitelman F. 2004. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia. Ann Med 36:492-503.
45. Karrman K, Forestier E, Andersen MK, Autio K, Borgström G, Heim S, Heinonen K, Hovland R, Kerndrup G, Johansson B. 2006. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: A Nordic series of cases diagnosed 1989-2005. Br J Haematol 135:352-354.
46. Kempski H, Chalker J, Chessells J, Sturt N, Brickell P, Webb J, MacDonald Clink J, Reeves B. 1999. An investigation of the t(12;21) rearrangement in children with B-precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods. Br J Haematol 105:684-689.
47. Kobayashi H, Satake N, Maseki N, Sakashita A, Kaneko Y. 1996. The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. Br J Haematol 94:105-111.
48. Konrad M, Metzler M, Panzer S, Östreicher I, Peham M, Repp R, Haas OA, Gadner H, Panzer-Grümayer ER. 2003. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic ,leukemia: Evidence for the persistence of a preleukemic clone. Blood 101:3635-3640.
49. Kuchinskaya E, Heyman M, Grandér D, Linderholm M, Söderhäll S, Zaritskey A, Nordgren A, Porwit-MacDonald A, Zueva E, Pawitan Y, Corcoran M, Nordenskjöld M, Blennow E. 2005. Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles. Eur J Haematol 74:466-480.
50. Lanza C, Volpe G, Basso G, Gottardi E, Barisone E, Spinelli M, Ricotti E, Cilli V, Perfetto F, Madon E, Saglio G. 1997. Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. Br J Haematol 97:460-462.
51. Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR, Pui CH, Shih LY. 1996. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:991-993.
52. Loh ML, Goldwasser MA, Silverman LB, Poon WM, Vattikuti S, Cardoso A, Neuberg DS, Shannon KM, Sallan SE, Gilliland DG. 2006. Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood 107:4508-4513.
53. Loh ML, Silverman LB, Young ML. Neuberg D, Golub TR, Sallan SE, Gilliland DG. 1998. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood 92:4792-4797.
54. Loncarevic IF, Roitzheim B, Ritterbach J, Viehmann S, Borkhardt A, Lampert F, Harbott J. 1999. Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion. Genes Chromosomes Cancer 24:272-277.
55. Ma SK, Wan TSK, Cheuk ATC, Fung LF, Chan GCF, Chan SY, Ha SY, Chan LC. 2001. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: A molecular cytogenetics study. Leukemia 15:1442-1447.
56. Magalhães IQ, Pombo-de-Oliveira MS, Bennett CA, Cordoba JC, Dobbin J, Ford AM, Greaves MF. 2000. TEL-AML1 fusion gene frequency in paediatric acute lymphoblastic leukaemia in Brazil. Br J Haematol 111:204-207.
57. Maia AT, Ford AM, Jalali GR, Harrison CJ, Taylor GM, Eden OB, Greaves MF. 2001. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood 98:478-482.
58. Maia AT, Koechling J, Corbett R, Metzler M, Wiemels JL, Greaves M. 2004. Protracted postnatal natural histories in childhood leukemia. Genes Chromosomes Cancer 39:335-340.
59. Maloney KW, McGavran L, Murphy JR, Odom LF, Stork L, Wei Q, Hunger SP. 1999. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification. Leukemia 13:1708-1712.
60. Martineau M, Clark R, Farrell DM, Hawkins JM, Moorman AV, Seeker-Walker LM. 1996. Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding. Genes Chromosomes Cancer 17:21-30.
61. Martineau M, Jalali GR, Barber KE, Broadfield ZJ, Cheung KL, Lilleyman J, Moorman AV, Richards S, Robinson HM, Ross F, Harrison CJ. 2005. ETV6/RUNX1 fusion at diagnosis and relapse: Some prognostic indications. Genes Chromosomes Cancer 43:54-71.
62. Martínez-Ramírez A, Urioste M, Contra T, Cantalejo A, Tavares A, Portera JA, López-Ibor B, Bernacer M, Soto C, Cigudosa JC, Benítez J. 2001. Fluorescence in situ hybridization study of TEL/ AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphoblastic leukemia. Haematologica 86:1245-1253.
63. Mathew S, Shurtleff SA, Raimondi SC. 2001. Novel cryptic, complex rearrangements involving ETV6-CBFA2 (TEL-AML1) genes identified by fluorescence in situ hybridization in pediatric patients with acute lymphoblastic leukemia. Genes Chromosomes Cancer 32:188-193.
64. McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Guo W, Loh ML, Smith MT 2003. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 37:36-43.
65. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JWG, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR. 1996. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252-4258.
66. Mitelman F, Johansson B, Mertens F. 2006. Mitelman database of chromosome aberrations in cancer. Available at http://cgap.nci. nih.gov/Chromosomes/ Mitelman
67. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, Hows JM, Navarrete C, Greaves M. 2002. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 99:8242-8247.
68. Morrow M, Horton S, Kioussis D, Brady HJM, Williams O. 2004. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 103:3890-3896.
69. Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, Misawa S. 1996. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 10:1463-1470.
70. Nordgren A, Heyman M, Sahlén S, Schoumans J, Söderhäll S, Nordenskjöld M, Blennow E. 2002. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: Detailed analysis of 70 cases. Eur J Haematol 68:31-41.
71. O'Connor HE, Butler TA, Clark R, Swanton S, Harrison CJ, Seeker-Walker LM, Foroni L. 1998. Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: A combined PCR and Southern blotting analysis. Leukemia 12:1099-1106.
72. Ozbek U, Sirma S, Agaoglu L, Yuksel L, Anak S, Yildiz I, Devecioglu O, Timur C, Meral A, Gedikoglu G. 2003. Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey. J Pediatr Hematol Oncol 25:204-208.
73. Pajor L, Lacza A, Jáksó P, Kajtár B. 2001. Characteristics of TEL/ AML-1 positive acute lymphoblastic leukemia in Hungarian children. Med Pediatr Oncol 37:409-411.
74. Pérez-Vera P, Montero-Ruiz O, Frías S, Ulloa-Avilés V, Cärdenas-Cardós R, Paredes-Aguilera R, Rivera-Luna R, Carnevale A. 2005. Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: Experience at a single institution. Cancer Genet Cytogenet 162:140-145.
75. Rafi SK, El Gebaly H, Qumsiyeh MB. 2000. ETV6/CBFA2 fusions in childhood B-cell precursor acute lymphoblastic leukemia with myeloid markers. Diagn Mol Pathol 9:184-189.
76. Raimondi SC, Shurtleff SA, Downing JR, Rubnitz J, Mathew S, Hancock M, Pui CH, Rivera GK, Grosveld GC, Behm FG. 1997. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood 90:4559-4566.
77. Raimondi SC, Zhou Y, Shurtleff SA, Rubnitz JE, Pui CH, Behm FG. 2006. Near-triploidy and near-tetraploidy in childhood acute lymphoblastic leukemia: Association with B-lineage blast cells carrying the ETV6-RUNX1 fusion, T-lineage immunophenotype, and favorable outcome. Cancer Genet Cytogenet 169:50-57.
78. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B. 1996a. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891-2899.
79. Raynaud S, Mauvieux L, Cayuela JM, Bastard C, Bilhou-Nabera C, Debuire B, Bories D, Boucheix C, Charrin C, Fière D, Gaben J. 1996b. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 10:1529-1530.
80. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi SC. 1999. Cytogenetic abnormalities associated with the t(12;21): A collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia 13:1325-1330.
81. Romana SP, Le Coniat M, Berger R. 1994. t(12;21): A new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186-191.
82. Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard OA, Berger R. 1996. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 10:167-170.
83. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. 1995a. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85: 3662-3670.
84. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA. 1995b. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263-4269.
85. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR. 2003. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102:2951-2959.
86. Rubnitz JE, Behm FG, Wichlan D, Ryan C, Sandlund JT, Ribeiro RC, Rivera GK, Hancock ML, Relling MV, Evans WE, Pui CH, Downing JR. 1999. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia 13:19-21.
87. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG. 1997. TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance. J Clin Oncol 15:1150-1157.
88. Satake N, Kobayashi H, Tsunematsu Y, Kawasaki H, Horikoshi Y, Koizumi S, Kaneko Y. 1997. Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21). Br J Haematol 97:607-611.
89. Seeger K, Buchwald D, Taube T, Peter A, von Stackelberg A, Schmitt G, Köchling J, Henze G. 1999. TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Leukemia 13:1469-1470.
90. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GCF, Pui CH, Grosveld G, Downing JR. 1995. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985-1989.
91. Spathas DH, Stewart J, Singer IO, Theriault A, Bovey M, Connor JM. 1999. Detection of t(12;21) in childhood acute lymphoblastic leukemia by fluorescence in situ hybridization. Cancer Genet Cytogenet 110:7-13.
92. Stams WAG, Beverloo HB, den Boer ML, de Menezes RX, Stigter RL, van Drunen E, Ramakers-van-Woerden NL, Loonen AH, van Wering ER, Janka-Schaub GE, Pieters R. 2006. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome. Leukemia 20:410-416.
93. Takahashi Y, Horibe K, Kiyoi H, Miyashita Y, Fukuda M, Mori H, Nozaki C, Hasegawa S, Kawabe T, Kato K, Kojima S, Matuyama T, Naoe T. 1998. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:190-195.
94. Trka J, Zuna J, Hrusak O, Kalinova M, Muzikova K, Lauschman H, Stary J. 1998. Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Leukemia 12:996-997.
95. Tsang KS, Li CK, Chik KW, Shing MMK, Tsoi WC, Ng MHL, Lau TT, Leung Y, Yuen PMP. 2001. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 68:91-98.
96. Tsuzuki S, Seto M, Greaves M, Enver T. 2004. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Proc Natl Acad Sci USA 101:8443-8448.
97. Uckun FM, Pallisgaacd N, Hokland P, Navara C, Narla R, Gaynon PS, Sather H, Heerema N. 2001. Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leuk Lymphoma 42:41-56.
98. UK Childhood Cancer Study Investigators. 2000. The United Kingdom Childhood Cancer Study: Objectives, materials and methods. Br J Cancer 82:1073-1102.
99. Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, Saha V, Biondi A, Greaves MF. 1999a. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354:1499-1503.
100. Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. 1999b. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 94:1057-1062.
101. Zen PRG, Lima MC, Coser VM, Silla L, Daudt L, Fernandes MS, Neumann J, Mattevi MS, Ortigara R, Paskulin GA. 2004. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia. Cancer Genet Cytogenet 151:68-72.
102. Zuna J, Ford AM, Peham M, Patel N, Saha V, Eckert C, Köchling J, Panzer-Grümayer R, Trka J, Greaves M. 2004. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clin Cancer Res 10:5355-5360.
103. Zuna J, Hruîsák O, Kalinová M, Muǐzí ková K, Starý J, Trka J. 1999. Significantly lower relapse rate for TEL/AML1-positive ALL. Leukemia 13:1633.